Careers
Contact
Menu
Skip to content
ABOUT US
OUR MISSION
OUR LEADERSHIP
OUR TEAM
BOARD OF DIRECTORS
SCIENTIFIC ADVISORS
PLATFORMS
SYNTHETIC BIOLOGY
CAR-TCR
GENE EDITING
IMMUNO ONCOLOGY ANTIBODIES
Nucleic acid drugs
PIPELINE
PARTNERSHIPS
JOINT VENTURES
COLLABORATIONS
WHOLLY-OWNED SORRENTO SUBSIDIA
NEWS
INVESTORS
EVENTS AND PRESENTATIONS
STOCK INFORMATION
CORPORATE GOVERNANCE
SEC DOCUMENTS
SERVICE
CONTACT
Chinese
English
NEWS RELEASES
Dr. Paul Dai, Chairman
« Back to News
MENU
ABOUT US
OUR MISSION
OUR LEADERSHIP
OUR TEAM
BOARD OF DIRECTORS
SCIENTIFIC ADVISORS
PLATFORMS
SYNTHETIC BIOLOGY
CAR-TCR
GENE EDITING
IMMUNO ONCOLOGY ANTIBODIES
Nucleic acid drugs
PIPELINE
PARTNERSHIPS
JOINT VENTURES
COLLABORATIONS
WHOLLY-OWNED SORRENTO SUBSIDIA
NEWS
INVESTORS
EVENTS AND PRESENTATIONS
STOCK INFORMATION
CORPORATE GOVERNANCE
SEC DOCUMENTS
SERVICE
CONTACT